Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8+ T Lymphocytes

Immunity

Volumn 42, Issue 5, 2015, Pages 929-941

  Yu, Wong ^a   Jiang, Ning ^a,e   Ebert, Peter J R ^a   Kidd, Brian A ^a,f   Müller, Sabina ^b,c   Lund, Peder J ^a   Juang, Jeremy ^a   Adachi, Keishi ^a,g   Tse, Tiffany ^a   Birnbaum, Michael E ^a   Newell, Evan W ^a,h   Wilson, Darrell M ^a   Grotenbreg, Gijsbert M ^d,i   Valitutti, Salvatore ^b,c   Quake, Stephen R ^a   Davis, Mark M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSERM   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^e The University of Texas at Austin   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g NAGASAKI UNIVERSITY   (Japan)

^h AGENCY FOR SCIENCE   (Singapore)

ⁱ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; CD45RA ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; EPITOPE; HLA A ANTIGEN; HY ANTIGEN; PREPROINSULIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ALPHABETA CD8+ T LYMPHOCYTE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; AVIAN INFLUENZA VIRUS; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL SPECIFICITY; CELL VIABILITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; HEPATITIS C VIRUS; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; INFLUENZA VIRUS A H5N1; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; ANIMAL; ANTIGENIC VARIATION; CYTOLOGY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY;

ANIMALS; ANTIGENIC VARIATION; CD8-POSITIVE T-LYMPHOCYTES; CLONAL DELETION; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MICE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SELF TOLERANCE;

EID: 84929676377     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.05.001     Document Type: Article

References (69)

1. Alanio C., Lemaitre F., Law H.K., Hasan M., Albert M.L. Enumeration of human antigen-specific naive CD8+ Tcells reveals conserved precursor frequencies. Blood 2010, 115:3718-3725.
2. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., von Boehmer H., Bronson R., Dierich A., Benoist C., Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002, 298:1395-1401.
3. Appay V., Dunbar P.R., Callan M., Klenerman P., Gillespie G.M., Papagno L., Ogg G.S., King A., Lechner F., Spina C.A., et al. Memory CD8+ Tcells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 2002, 8:379-385.
4. Barnea E., Beer I., Patoka R., Ziv T., Kessler O., Tzehoval E., Eisenbach L., Zavazava N., Admon A. Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens. Eur. J. Immunol. 2002, 32:213-222.
5. Bautista J.L., Lio C.W., Lathrop S.K., Forbush K., Liang Y., Luo J., Rudensky A.Y., Hsieh C.S. Intraclonal competition limits the fate determination of regulatory Tcells in the thymus. Nat. Immunol. 2009, 10:610-617.
6. Berg L.J., Fazekas de St Groth B., Pullen A.M., Davis M.M. Phenotypic differences between alpha beta versus beta T-cell receptor transgenic mice undergoing negative selection. Nature 1989, 340:559-562.
7. Blank M., Barzilai O., Shoenfeld Y. Molecular mimicry and auto-immunity. Clin. Rev. Allergy Immunol. 2007, 32:111-118.
8. Boise L.H., Minn A.J., Noel P.J., June C.H., Accavitti M.A., Lindsten T., Thompson C.B. CD28 costimulation can promote Tcell survival by enhancing the expression of Bcl-XL. Immunity 1995, 3:87-98.
9. Bouneaud C., Kourilsky P., Bousso P. Impact of negative selection on the Tcell repertoire reactive to a self-peptide: a large fraction of Tcell clones escapes clonal deletion. Immunity 2000, 13:829-840.
10. Burnet F.M. The Clonal Selection Theory of Acquired Immunity 1959, Vanderbilt University Press, Nashville.
11. Chen R., Mias G.I., Li-Pook-Than J., Jiang L., Lam H.Y., Chen R., Miriami E., Karczewski K.J., Hariharan M., Dewey F.E., et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012, 148:1293-1307.
12. Choi S., Schwartz R.H. Molecular mechanisms for adaptive tolerance and other Tcell anergy models. Semin. Immunol. 2007, 19:140-152.
13. Davis M.M., Bjorkman P.J. T-cell antigen receptor genes and T-cell recognition. Nature 1988, 334:395-402.
14. Delluc S., Ravot G., Maillere B. Quantification of the preexisting CD4 T-cell repertoire specific for human erythropoietin reveals its immunogenicity potential. Blood 2010, 116:4542-4545.
15. Diehn M., Cho R.W., Lobo N.A., Kalisky T., Dorie M.J., Kulp A.N., Qian D., Lam J.S., Ailles L.E., Wong M., et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009, 458:780-783.
16. Enouz S., Carrié L., Merkler D., Bevan M.J., Zehn D. Autoreactive Tcells bypass negative selection and respond to self-antigen stimulation during infection. J.Exp. Med. 2012, 209:1769-1779.
17. Fulton R.B., Hamilton S.E., Xing Y., Best J.A., Goldrath A.W., Hogquist K.A., Jameson S.C. The TCR's sensitivity to self peptide-MHC dictates the ability of naive CD8(+) Tcells to respond to foreign antigens. Nat. Immunol. 2015, 16:107-117.
18. Herman A., Kappler J.W., Marrack P., Pullen A.M. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 1991, 9:745-772.
19. Hogquist K.A., Baldwin T.A., Jameson S.C. Central tolerance: learning self-control in the thymus. Nat. Rev. Immunol. 2005, 5:772-782.
20. Huesmann M., Scott B., Kisielow P., von Boehmer H. Kinetics and efficacy of positive selection in the thymus of normal and Tcell receptor transgenic mice. Cell 1991, 66:533-540.
21. Jenkins M.K., Chu H.H., McLachlan J.B., Moon J.J. On the composition of the preimmune repertoire of Tcells specific for Peptide-major histocompatibility complex ligands. Annu. Rev. Immunol. 2010, 28:275-294.
22. Jensen K.D., Su X., Shin S., Li L., Youssef S., Yamasaki S., Steinman L., Saito T., Locksley R.M., Davis M.M., et al. Thymic selection determines gammadelta Tcell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity 2008, 29:90-100.
23. Kappler J.W., Roehm N., Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987, 49:273-280.
24. Kent S.C., Chen Y., Bregoli L., Clemmings S.M., Kenyon N.S., Ricordi C., Hering B.J., Hafler D.A. Expanded Tcells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 2005, 435:224-228.
25. Kisielow P., Blüthmann H., Staerz U.D., Steinmetz M., von Boehmer H. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 1988, 333:742-746.
26. Kotturi M.F., Scott I., Wolfe T., Peters B., Sidney J., Cheroutre H., von Herrath M.G., Buchmeier M.J., Grey H., Sette A. Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ Tcell immunodominance. J.Immunol. 2008, 181:2124-2133.
27. Kronenberg D., Knight R.R., Estorninho M., Ellis R.J., Kester M.G., de Ru A., Eichmann M., Huang G.C., Powrie J., Dayan C.M., et al. Circulating preproinsulin signal peptide-specific CD8 Tcells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cells. Diabetes 2012, 61:1752-1759.
28. Legoux F., Debeaupuis E., Echasserieau K., De La Salle H., Saulquin X., Bonneville M. Impact of TCR reactivity and HLA phenotype on naive CD8 Tcell frequency in humans. J.Immunol. 2010, 184:6731-6738.
29. + Tcells with an anergic phenotype in healthy individuals. Science 2014, 346:1536-1540.
30. Mallone R., Kochik S.A., Reijonen H., Carson B., Ziegler S.F., Kwok W.W., Nepom G.T. Functional avidity directs T-cell fate in autoreactive CD4+ Tcells. Blood 2005, 106:2798-2805.
31. Mallone R., Martinuzzi E., Blancou P., Novelli G., Afonso G., Dolz M., Bruno G., Chaillous L., Chatenoud L., Bach J.M., van Endert P. CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes. Diabetes 2007, 56:613-621.
32. Martinuzzi E., Novelli G., Scotto M., Blancou P., Bach J.M., Chaillous L., Bruno G., Chatenoud L., van Endert P., Mallone R. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment. Diabetes 2008, 57:1312-1320.
33. McCaughtry T.M., Baldwin T.A., Wilken M.S., Hogquist K.A. Clonal deletion of thymocytes can occur in the cortex with no involvement of the medulla. J.Exp. Med. 2008, 205:2575-2584.
34. McGuire H.M., Vogelzang A., Hill N., Flodström-Tullberg M., Sprent J., King C. Loss of parity between IL-2 and IL-21 in the NOD Idd3 locus. Proc. Natl. Acad. Sci. USA 2009, 106:19438-19443.
35. *0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects Tcell recognition. Immunity 1997, 6:273-281.
36. Moon J.J., Chu H.H., Pepper M., McSorley S.J., Jameson S.C., Kedl R.M., Jenkins M.K. Naive CD4(+) Tcell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 2007, 27:203-213.
37. Moon J.J., Dash P., Oguin T.H., McClaren J.L., Chu H.H., Thomas P.G., Jenkins M.K. Quantitative impact of thymic selection on Foxp3+ and Foxp3- subsets of self-peptide/MHC class II-specific CD4+ Tcells. Proc. Natl. Acad. Sci. USA 2011, 108:14602-14607.
38. Nakayama M., Abiru N., Moriyama H., Babaya N., Liu E., Miao D., Yu L., Wegmann D.R., Hutton J.C., Elliott J.F., Eisenbarth G.S. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 2005, 435:220-223.
39. Newell E.W., Klein L.O., Yu W., Davis M.M. Simultaneous detection of many T-cell specificities using combinatorial tetramer staining. Nat. Methods 2009, 6:497-499.
40. Newell E.W., Sigal N., Bendall S.C., Nolan G.P., Davis M.M. Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ Tcell phenotypes. Immunity 2012, 36:142-152.
41. Obar J.J., Khanna K.M., Lefrançois L. Endogenous naive CD8+ Tcell precursor frequency regulates primary and memory responses to infection. Immunity 2008, 28:859-869.
42. Ohashi P.S., Oehen S., Buerki K., Pircher H., Ohashi C.T., Odermatt B., Malissen B., Zinkernagel R.M., Hengartner H. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991, 65:305-317.
43. Pittet M.J., Valmori D., Dunbar P.R., Speiser D.E., Liénard D., Lejeune F., Fleischhauer K., Cerundolo V., Cerottini J.C., Romero P. High frequencies of naive Melan-A/MART-1-specific CD8(+) Tcells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J.Exp. Med. 1999, 190:705-715.
44. Rubio V., Stuge T.B., Singh N., Betts M.R., Weber J.S., Roederer M., Lee P.P. Exvivo identification, isolation and analysis of tumor-cytolytic Tcells. Nat. Med. 2003, 9:1377-1382.
45. Savage P.A., Boniface J.J., Davis M.M. A kinetic basis for Tcell receptor repertoire selection during an immune response. Immunity 1999, 10:485-492.
46. Schmidt J., Neumann-Haefelin C., Altay T., Gostick E., Price D.A., Lohmann V., Blum H.E., Thimme R. Immunodominance of HLA-A2-restricted hepatitis C virus-specific CD8+ Tcell responses is linked to naive-precursor frequency. J.Virol. 2011, 85:5232-5236.
47. Sha W.C., Nelson C.A., Newberry R.D., Kranz D.M., Russell J.H., Loh D.Y. Positive and negative selection of an antigen receptor on Tcells in transgenic mice. Nature 1988, 336:73-76.
48. Silverstein A.M. Autoimmunity versus horror autotoxicus: the struggle for recognition. Nat. Immunol. 2001, 2:279-281.
49. Skowera A., Ellis R.J., Varela-Calviño R., Arif S., Huang G.C., Van-Krinks C., Zaremba A., Rackham C., Allen J.S., Tree T.I., et al. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J.Clin. Invest. 2008, 118:3390-3402.
50. Smith K.A. Interleukin-2: inception, impact, and implications. Science 1988, 240:1169-1176.
51. Stuge T.B., Holmes S.P., Saharan S., Tuettenberg A., Roederer M., Weber J.S., Lee P.P. Diversity and recognition efficiency of Tcell responses to cancer. PLoS Med. 2004, 1:e28.
52. Su L.F., Kidd B.A., Han A., Kotzin J.J., Davis M.M. Virus-specific CD4(+) memory-phenotype Tcells are abundant in unexposed adults. Immunity 2013, 38:373-383.
53. Todd J.A. Etiology of type 1 diabetes. Immunity 2010, 32:457-467.
54. Toebes M., Coccoris M., Bins A., Rodenko B., Gomez R., Nieuwkoop N.J., van de Kasteele W., Rimmelzwaan G.F., Haanen J.B., Ovaa H., Schumacher T.N. Design and use of conditional MHC class I ligands. Nat. Med. 2006, 12:246-251.
55. Tonegawa S. Somatic generation of antibody diversity. Nature 1983, 302:575-581.
56. Uematsu Y., Ryser S., Dembić Z., Borgulya P., Krimpenfort P., Berns A., von Boehmer H., Steinmetz M. In transgenic mice the introduced functional Tcell receptor beta gene prevents expression of endogenous beta genes. Cell 1988, 52:831-841.
57. van den Beemd R., Boor P.P., van Lochem E.G., Hop W.C., Langerak A.W., Wolvers-Tettero I.L., Hooijkaas H., van Dongen J.J. Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 2000, 40:336-345.
58. Velthuis J.H., Unger W.W., Abreu J.R., Duinkerken G., Franken K., Peakman M., Bakker A.H., Reker-Hadrup S., Keymeulen B., Drijfhout J.W., et al. Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers. Diabetes 2010, 59:1721-1730.
59. Vidović D., Matzinger P. Unresponsiveness to a foreign antigen can be caused by self-tolerance. Nature 1988, 336:222-225.
60. Villar H.O., Kauvar L.M. Amino acid preferences at protein binding sites. FEBS Lett. 1994, 349:125-130.
61. von Boehmer H. Developmental biology of Tcells in Tcell-receptor transgenic mice. Annu. Rev. Immunol. 1990, 8:531-556.
62. von Boehmer H., Kisielow P. Negative selection of the T-cell repertoire: where and when does it occur?. Immunol. Rev. 2006, 209:284-289.
63. Wardemann H., Yurasov S., Schaefer A., Young J.W., Meffre E., Nussenzweig M.C. Predominant autoantibody production by early human B cell precursors. Science 2003, 301:1374-1377.
64. Weinschenk T., Gouttefangeas C., Schirle M., Obermayr F., Walter S., Schoor O., Kurek R., Loeser W., Bichler K.H., Wernet D., et al. Integrated functional genomics approach for the design of patient-individual antitumor vaccines. Cancer Res. 2002, 62:5818-5827.
65. Wing K., Sakaguchi S. Regulatory Tcells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 2010, 11:7-13.
66. Wölfl M., Rutebemberwa A., Mosbruger T., Mao Q., Li H.M., Netski D., Ray S.C., Pardoll D., Sidney J., Sette A., et al. Hepatitis C virus immune escape via exploitation of a hole in the Tcell repertoire. J.Immunol. 2008, 181:6435-6446.
67. Zehn D., Bevan M.J. T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. Immunity 2006, 25:261-270.
68. Zehn D., Lee S.Y., Bevan M.J. Complete but curtailed T-cell response to very low-affinity antigen. Nature 2009, 458:211-214.
69. Zeng R., Spolski R., Finkelstein S.E., Oh S., Kovanen P.E., Hinrichs C.S., Pise-Masison C.A., Radonovich M.F., Brady J.N., Restifo N.P., et al. Synergy of IL-21 and IL-15 in regulating CD8+ Tcell expansion and function. J.Exp. Med. 2005, 201:139-148.